Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Common Stock Repurchased

Cash spent buying back the company's own shares.

Aurora Cannabis Inc.TSX: ACB.TO

Common Stock Repurchased · Q4 FY2026 · quarter ended Mar 2026

Common stock repurchased outflow grows to CA$0

Q4 FY2026 common stock repurchased was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month common stock repurchased was CA$0.

Context

  • Common stock repurchased amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
  • Common stock repurchased increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearMar 2026
CA$0— YoY
LTMMar 2026
CA$0— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

CAD · from the cash flow

Latest · FY2026
0 CAD
Year-over-year change
—

Common Stock Repurchased vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Common stock repurchased amounts to 0.0% of revenue for ACB.TO, versus a peer median of 0.0%.
ACB.TO Competitors
Common Stock Repurchased for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$5.41M USD+314580.5%+40.2%10.6%
TSND.TOTerrAscend Corp.LTM Mar 2026$255.04K USD-42.8%—0.1%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$0 CAD——0.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD+100.0%—0.0%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$0 CAD——0.0%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$0 CAD——0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding ACB.TO) —+100.0%+40.2%0.0%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income(1.72B)(265.33M)(59.05M)15.76M(58.62M)
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
Deferred Income Tax(2.19M)(18.4M)(1.67M)(3.19M)55K
Stock-Based Compensation13.76M16.89M12.72M11.52M7.29M
Change in Working Capital52.65M(25.12M)(15.63M)10.21M(9.21M)
Accounts Receivables18.34M5.53M(4.33M)5.24M(8.15M)
Inventory21.07M49.03M3.62M(15.05M)7.44M
Accounts Payables6.77M(8.06M)(15.7M)14.91M(8.04M)
Other Working Capital6.48M(71.61M)790K5.11M(9.21M)
Other Non-Cash Items1.45B190.11M(37.96M)(40.85M)54.32M
Operating Cash Flow(110.27M)(115.82M)(68.51M)16.01M(13.51M)
Capital Expenditures(32.21M)(12.13M)(16.96M)(18.86M)(22.55M)
Acquisitions (Net)(23.42M)(18.54M)(5.55M)01.1M
Purchases of Investments00000
Sales of Investments03.36M4.99M5.49M0
Other Investing Activities19.46M16K12.02M(956K)(51.98M)
Investing Cash Flow(36.17M)(27.29M)(5.49M)(14.33M)(73.43M)
Debt Repayment(170.83M)—(85.76M)(805K)(5.02M)
Common Stock Issued350.19M73.19M37.93M00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(31.58M)(95.21M)(89K)689K(154K)
Financing Cash Flow147.78M(56.48M)(47.92M)(116K)9.76M
Effect of Forex Changes15.01M15.54M297K264K4.33M
Net Change in Cash16.35M(140.01M)(121.5M)1.83M(72.85M)
Free Cash Flow(142.48M)(127.95M)(85.46M)(2.85M)(36.06M)

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.